Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Ethics

University of Toronto

$99,050.00

At the intersection of clinical ethics and harm reduction: Clinician perspectives on reducing discharges against medical advice for substance using patients living with HIV and Hepatitis C

EF 2012-13

Résumé
Existing research suggests that as many as 70% of people living with HIV/AIDs (PHAs) used illicit drugs or reported hazardous alcohol use in the previous year. These findings are concerning because substance use has a negative impact on anti-retroviral treatment (ARV) adherence, HIV disease progression, and HIV transmission. People who use illicit drugs and/or drink hazardously have very high rates of emergency room visits and hospital admissions. However, when they go to the hospital for care they often experience stigma, may receive substandard care, and leave hospital against medical advice. This is complex care and public health issue with important ethical dimensions. We propose to conduct four phase project and improve the capacity to understand and respond to these issues. First, we will complete interviews to understand how substance use among PHA/HCVs influences the care provided by physicians, nurses and social workers in acute care settings. Second, we will develop a framework to analyse the ethical challenges faced by clinicians using existing literature and empirical results. Third, we will host a consultation with key stakeholders (i.e., clinicians, policy makers, PHA/HCVs) to analyse the study findings and begin to develop a framework for ethical decision making as it relates to the care of PHA/HCVs who use substances. Fourth, we will increase our team and develop a larger program of research to test and disseminate a framework for ethical decisional making as it relates to the care of PHA/HCVs who use substances while in hospital.
Programme
Catalyst Grant: Ethics
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
281558
Name
Strike Carol J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Catalyst Grant : Ethics (2016-2017)
Projecttitle
At the intersection of clinical ethics and harm reduction: Clinician perspectives on reducing discharges against medical advice for substance using patients living with HIV and Hepatitis C
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$99,050
Cihrequipment2
$0
Programname2
Catalyst Grant: Ethics
Keyworddelim
Acute Care; Decision Making Frameworks; Equity; Ethics; Hiv/Aids; Substance Use
Abstract
Existing research suggests that as many as 70% of people living with HIV/AIDs (PHAs) used illicit drugs or reported hazardous alcohol use in the previous year. These findings are concerning because substance use has a negative impact on anti-retroviral treatment (ARV) adherence, HIV disease progression, and HIV transmission. People who use illicit drugs and/or drink hazardously have very high rates of emergency room visits and hospital admissions. However, when they go to the hospital for care they often experience stigma, may receive substandard care, and leave hospital against medical advice. This is complex care and public health issue with important ethical dimensions. We propose to conduct four phase project and improve the capacity to understand and respond to these issues. First, we will complete interviews to understand how substance use among PHA/HCVs influences the care provided by physicians, nurses and social workers in acute care settings. Second, we will develop a framework to analyse the ethical challenges faced by clinicians using existing literature and empirical results. Third, we will host a consultation with key stakeholders (i.e., clinicians, policy makers, PHA/HCVs) to analyse the study findings and begin to develop a framework for ethical decision making as it relates to the care of PHA/HCVs who use substances. Fourth, we will increase our team and develop a larger program of research to test and disseminate a framework for ethical decisional making as it relates to the care of PHA/HCVs who use substances while in hospital.
Competitiondate
201303
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Strike, Carol J
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $99,050~ $0~